EMA fast tracks review of a medicine for metastatic pancreatic cancer

发布时间：2026-07-15 16:32

EMA’s human medicines committee (CHMP) has started a phased review of data on daraxonrasib, a medicine intended for the treatment of metastatic pancreatic cancer. A phased…